Overexpression of OSM and/or OSMRβ is seen more commonly in a multitude of advanced tumors and is linked to decreased patient survival in several cancer types, including breast, cervical, colon, pancreatic, lung, and brain cancer (109, 153, 165, 177, 192, 242). This evidence concerns the gene OSM and brain cancer.